22.04.2018
:
2 1,5 95
. /. 200 14 13251 pfizer inc
D3 . / 30 130 beres
- 30 - -
. / 0,25 50 32
- 5 / . 5 14
- /. 3 % . 10 5 201
- /. 400 135
- /. 200 120
. 1 20 90 novartis consu
- /. 1 / . 2 5 109 novartis consu
. /. 30 30 - -
. 10 20 7
- . 2,5 30 121
. 80 60 407 krka
. 80 20 170 krka
. 250 / 200 244 glaxosmithklin
. 400 . 100 568 pharmascience
. 300 . 100 152 pharmascience
. 300 30 175 pharmascience
/. 100 33
. 60 101 glenmark
-6 . 100 , 6 - glenmark -
10 / . 30 131.35 glenmark
- /. 10000 / . 1 10 3023 pfizer inc
- 2 1 210 , - - -
6 , 40
. /. 4 ., . 1 - -
. 100 . 100 - pharmascience-
. 100 30 - pharmascience-
. /- /. 4000 . 1 - bio sidus -
. /- /. 2000 . 1 379 bio sidus
(B220) DYDUS 250 , . SB2 - berren handlow-
(B221) DYDUS 250 , . SB2 56.1 berren handlow
(B121) DYDUS 125 , . SB2 - berren handlow-
(B120) DYDUS 125 , . SB2 - berren handlow-
SB2 DYDUS - berren handlow-
SG22 DYDUS - berren handlow-
SB1 DYDUS - berren handlow-
SB3 DYDUS - berren handlow-
20 11
- 2 1 210 , - - -
O.B. 32 - johnson johnso-
- . 150 1 21
- . 100 10 58
- . 50 10 34
- /. . 100 . 5 1 216 ebewe pharma
- /. . 1000 . 20 1 834 ebewe pharma
- /. . 500 . 10 1 238 ebewe pharma
200 . . . 10 - -
 

0.. - 490 - 491 - 492 - 493 - 494 - 495 - 496 - ..572



, , (c) , , 067-9566747